3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
126
Gastrointestinal
59
Genitourinary
36
Thoracic
30
Other hematologic neoplasm
25
Lymphoid
25
Other
22
Gynecologic
15
Tumor-Agnostic
14
Plasma cell
10
Head & Neck
10
CNS
8
Endocrine
4
Dermatologic
3
Sarcoma
2
Other solid neoplasm
2
Myeloid
2
Other neoplasm
1
Classical hematology
1
Conditions
Myelodysplastic Syndromes
1
Cytopenia
1
Interventions
fludarabine phosphate
9
Cyclophosphamide
8
Cyclosporine
7
Busulfan
6
Antilymphocyte Serum
6
fludarabine
5
Melphalan
5
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
Rivaroxaban
3
Radiotherapy
3
Methylprednisolone
3
Filgrastim
3
Cord Blood Stem Cell Transplantation
3
thymoglobulin
2
ferric carboxymaltose
2
apixaban
2
Whole-Body Irradiation
2
Therapeutics
2
Methotrexate
2
Heparin, Low-Molecular-Weight
2
Hematologic Tests
2
Genetic Counseling
2
Fondaparinux
2
Enoxaparin
2
Educational Status
2
Drug Therapy
2
Dalteparin
2
Cytarabine
2
sulforaphane
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Exercise
×
Classical hematology
×
Clear all
NCT06773871
2025-08-19
HemEx
Rigshospitalet, Denmark
Phase NA
Recruiting
36 enrolled